MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1016/j.ejim.2022.04.017

Медицинская библиотека · European journal of internal medicine · 2022

Epidemiological and genetic features of anti-3‑hydroxy-3-methylglutaryl-CoA reductase necrotizing myopathy: Single-center experience and literature review.

Prieto-Peña Diana, Ocejo-Vinyals Javier G, Mazariegos-Cano Joel, Pelayo-Negro Ana L, Remuzgo-Martínez Sara, Genre Fernanda, García-Dorta Alicia, Renuncio-García Mónica, Martínez-Taboada Víctor M, García-Ibarbia Carmen, Sánchez-Martín Julio, López-Hoyos Marcos, Blanco Ricardo, González-Gay Miguel A, Hernández José L

СтатьяОбзорПеревод в очереди

Аннотация

OBJECTIVE

To characterize the demographic, genetic, clinical, and serological features of patients with anti-3‑hydroxy-3-methylglutaryl-CoA reductase (HMGCR) immune-mediated necrotizing myopathy (IMNM) in a region of northern Spain.

METHODS

Study of all patients diagnosed with anti-HMGCR IMNM during a 5-year period at a reference hospital in northern Spain. Besides clinical and laboratory data, we analyzed the genetic influence of HLA genes and the rs4149056 (c.521T>C) single nucleotide polymorphism (SNP) in the SLCO1B1 gene.

RESULTS

8 patients (5 women, 3 men) with a mean ± SD age of 64.9 ± 7.3 years, fulfilled the criteria for anti-HMGCR IMNM. The incidence rate was 0.6 per 100.000 person-years and the prevalence 3 per 100.000 population. All patients had been exposed to statins. All of them had predominant lower limb proximal and symmetric muscle weakness that was severe in 2 and had elevated serum CK levels with a median [IQR] of 4488 [2538-9194] IU/L. Serum 25‑hydroxy vitamin D levels were decreased in all patients in whom it was determined. The 3 patients with a previous diagnosis of hypothyroidism had abnormal levels of TSH at the time of diagnosis. All patients experienced improvement with different schemes of immunosuppressive therapy. Noteworthy, 7 of 8 patients carried the HLA-DRB1*11 allele. The frequency of the rs4149056 C allele in the SLCO1B1 gene (12.5%) was similar to that of the general population.

CONCLUSION

In northern Spain, anti-HMGCR IMNM preferentially affects people over 50 years of age who are carriers of the HLA-DRB1*11 allele and take statins. Both low vitamin D levels and hypothyroidism may play a potential predisposing role in the development of this disease.

Для цитирования: Prieto-Peña Diana, Ocejo-Vinyals Javier G, Mazariegos-Cano Joel, Pelayo-Negro Ana L, Remuzgo-Martínez Sara, Genre Fernanda, García-Dorta Alicia, Renuncio-García Mónica, Martínez-Taboada Víctor M, García-Ibarbia Carmen, Sánchez-Martín Julio, López-Hoyos Marcos, Blanco Ricardo, González-Gay Miguel A, Hernández José L. Epidemiological and genetic features of anti-3‑hydroxy-3-methylglutaryl-CoA reductase necrotizing myopathy: Single-center experience and literature review.. European journal of internal medicine. 2022. DOI: 10.1016/j.ejim.2022.04.017.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.